Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioGenex is a global leader in molecular pathology, specializing in the development and manufacturing of automated staining systems and reagents for cancer diagnosis. The company provides a comprehensive suite of products including primary antibodies, molecular probes, and detection systems for immunohistochemistry (IHC) and in situ hybridization (ISH). Their flagship Xmatrx and i6000 platforms automate complex laboratory workflows, enhancing precision and efficiency in clinical diagnostics. BioGenex serves hospitals, diagnostic laboratories, and research institutions worldwide, focusing on personalized medicine and targeted therapies. By integrating advanced technology with high-quality reagents, the company enables pathologists to deliver accurate and timely results for patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Genex Laboratories.